Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Douglas Ireland is a highly respected market manager overseeing Wedbush Securities' offices in Newport Beach, San Diego, ...

Tesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives ...

New York (CNN) — US stocks slid Thursday and the S&P 500 closed in correction, down more than 10% from its record high in ...

Analysts at Wedbush believe Palantir could secure additional government contracts following channel checks in Washington, D.C ...

Sutro Biopharma (NASDAQ:STRO – Get Free Report) was downgraded by research analysts at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Friday, MarketBeat.com ...

After doing channel checks inside Washington, D.C., Wedbush Securities has added confidence that Palantir Technologies (PLTR) ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at Wedbush in a ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...